Partial Anomalous Pulmonary Venous Return With Sinus Venosus ASD: CT Diagnosis and Surgical Planning
When Palpitations Are Not Just an Arrhythmia
A man in his seventies presented with palpitations.
At first glance, the clinical problem appeared straightforward. Palpitations in an older adult commonly lead to an electrocardiogram, ambulatory rhythm monitoring, and evaluation for ischemic or structural heart disease.
But his chest radiograph contained a second message.
The cardiac silhouette was enlarged, the main and central pulmonary arteries were prominent, and there was a suggestion of a small left pleural effusion. The combination raised a more important question:
Why is the right side of the heart enlarged?
That question changes the diagnostic pathway.
The eventual CT examination demonstrated a complex but highly characteristic anatomy. The right upper pulmonary vein drained toward the superior vena cava, while the right middle pulmonary venous drainage also entered the right-sided circulation in association with a superior sinus venosus atrial septal defect. The right lower pulmonary vein, in contrast, drained normally into the left atrium.
This is the critical distinction.
The patient did not have total anomalous pulmonary venous return. He had partial anomalous pulmonary venous return (PAPVR) associated with a sinus venosus atrial septal defect.
The case illustrates an important principle in adult cardiovascular imaging:
When unexplained right-heart enlargement, pulmonary arterial enlargement, and an atrial arrhythmia occur together, the radiologist should actively search for an occult left-to-right shunt.
The source case describes this exact pattern and emphasizes that the pulmonary veins must be followed individually rather than simply labeling one abnormal vessel.
Learning Objectives
By the end of this review, the reader should be able to:
Explain the anatomical basis of partial anomalous pulmonary venous return.
Recognize the relationship between PAPVR and sinus venosus atrial septal defect.
Systematically trace pulmonary venous drainage on contrast-enhanced CT.
Understand how chronic left-to-right shunting produces right-heart and pulmonary arterial enlargement.
Distinguish PAPVR from TAPVR, scimitar syndrome, pulmonary venous varix, and other vascular anomalies.
Understand how CT, cardiac MRI, echocardiography, and contemporary AI tools complement one another in diagnosis and management.
1. Anatomy: Start With the Destination of the Blood
Normal pulmonary venous anatomy is deceptively simple.
Oxygenated blood travels from the pulmonary capillary bed through the pulmonary veins into the left atrium. In the usual arrangement, four major pulmonary veins—right superior, right inferior, left superior, and left inferior—connect to the left atrium.
PAPVR represents a developmental abnormality in which one or more pulmonary veins connect to the systemic venous circulation rather than exclusively to the left atrium.
The abnormal connection may involve:
Superior vena cava
Right atrium
Inferior vena cava
Innominate vein
Other systemic venous structures
The most clinically important adult pattern is the connection of the right upper pulmonary vein to the SVC, particularly when a superior sinus venosus defect is present. This association is also specifically recognized in the AHA/ACC adult congenital heart disease guideline.
Figure 1. Normal and Abnormal Pulmonary Venous Anatomy
Schematic comparison of normal pulmonary venous return and PAPVR. In normal anatomy, all pulmonary veins drain oxygenated blood into the left atrium. In PAPVR, one or more pulmonary veins instead connect to the systemic venous circulation, producing additional right-sided blood flow.
2. Why Sinus Venosus ASD Matters
Sinus venosus atrial septal defects are anatomically different from the more familiar secundum ASD.
A superior sinus venosus defect is located near the junction of the SVC and right atrium and is strongly associated with anomalous right-sided pulmonary venous drainage.
This relationship is clinically important because the ASD and PAPVR together can produce a larger effective left-to-right shunt than either lesion considered in isolation.
The source case emphasizes two structures that should always be assessed together:
The SVC–right atrial junction.
The drainage pathway of the right upper pulmonary vein.
The radiologist should therefore avoid treating the pulmonary venous anomaly and atrial septal defect as unrelated incidental findings.
They are frequently part of the same developmental anatomical problem.
3. Pathophysiology: Why Does the Right Heart Enlarge?
The easiest way to understand PAPVR is to follow the blood.
Consider a right upper pulmonary vein that drains into the SVC.
Blood leaves the pulmonary circulation oxygenated, enters the anomalous pulmonary vein, reaches the SVC, and then returns to the right atrium.
Instead of completing the normal:
Pulmonary circulation → left atrium → left ventricle → systemic circulation
the abnormal portion effectively becomes:
Pulmonary circulation → systemic vein → right atrium → right ventricle → pulmonary circulation
The result is additional pulmonary blood flow.
Over years, the right atrium and right ventricle must accommodate this excess volume.
The sequence can be conceptualized as:
PAPVR → increased right-sided preload → right atrial/right ventricular enlargement → increased pulmonary blood flow → pulmonary arterial enlargement → possible pulmonary vascular remodeling → pulmonary hypertension
The presence of a sinus venosus ASD can further facilitate abnormal interatrial flow.
The source case describes right-heart enlargement, pulmonary arterial enlargement, increased pulmonary vascularity, arrhythmia, and eventually pulmonary hypertension as potential consequences of chronic volume loading.
Figure 2. Pathophysiological Cascade
Chronic anomalous pulmonary venous drainage redirects oxygenated pulmonary venous blood into the right-sided circulation. The resulting left-to-right shunt increases right atrial and right ventricular preload and may progressively enlarge the pulmonary arteries and alter pulmonary vascular physiology.
4. Epidemiology
PAPVR is uncommon in routine clinical practice, although its true prevalence is probably higher than the number of clinically diagnosed cases suggests.
The source material cites estimates around 0.4–0.7%, while one adult CT series identified PAPVC in approximately 0.2% of examinations. Sinus venosus defects account for a minority of ASDs but have a particularly strong association with anomalous pulmonary venous drainage.
Table 1. Epidemiologic and Clinical Profile of PAPVR
| Parameter | Clinical Interpretation |
|---|---|
| Overall frequency | Uncommon congenital cardiovascular anomaly |
| Typical detection | Often incidental or discovered during evaluation of right-heart enlargement |
| Age at presentation | Highly variable; some patients remain clinically silent into adulthood |
| Sex | No sufficiently specific sex pattern should be used diagnostically |
| Important association | Sinus venosus ASD |
| Common anomalous connection | Right upper pulmonary vein → SVC |
| Major physiological consequence | Chronic left-to-right shunting |
| Important complications | Right-heart enlargement, arrhythmia, pulmonary hypertension |
| Detection challenge | Abnormal venous pathways may be overlooked on routine imaging |
Prevalence estimates vary according to whether the population is examined by echocardiography, CT, MRI, autopsy, or another modality. A contemporary CT-focused review similarly emphasizes substantial morphological heterogeneity in PAPVC.
5. Clinical Presentation: The Adult Who Was “Fine” for Decades
PAPVR does not necessarily produce symptoms in childhood.
A small anomalous connection may produce only a modest shunt. The patient can therefore remain asymptomatic until the physiological reserve of the cardiovascular system declines with age.
Symptoms may include:
Palpitations
Exertional dyspnea
Fatigue
Reduced exercise tolerance
Chest discomfort
Atrial arrhythmia
Symptoms related to pulmonary hypertension
Right-sided heart failure
In the present case, palpitations were the clinical entry point.
This is important because palpitations can easily become a diagnostic endpoint rather than a clue.
A patient may undergo ECG and Holter monitoring, but if imaging demonstrates right atrial and right ventricular enlargement, the clinician should ask whether structural remodeling has created the arrhythmogenic substrate.
The source case specifically highlights the combination of palpitations, right-heart enlargement, and pulmonary arterial enlargement as a reason to search for a structural congenital heart disease.
6. Chest Radiography: The First Clue, Not the Final Diagnosis
Figure 3. Chest AP Radiograph
Chest radiograph demonstrating enlargement of the cardiac silhouette and prominence of the main and central pulmonary arteries. A small left pleural effusion is also suspected.
Radiologist Interpretation:
The radiograph does not directly demonstrate PAPVR in most patients. Its value lies in recognizing the physiological consequences of chronic pulmonary overcirculation and right-sided cardiac volume loading.
What Should the Radiologist Ask?
When the heart is enlarged, ask:
Is the enlargement predominantly right-sided?
When the pulmonary arteries are enlarged, ask:
Is there evidence of chronic increased pulmonary blood flow or pulmonary hypertension?
When both are present, ask:
Could there be an occult congenital left-to-right shunt?
The source case emphasizes that chest radiography should be regarded as a screening clue that prompts echocardiography, CT, or MRI rather than as a definitive diagnostic test for PAPVR.
7. The Decisive Examination: Contrast-Enhanced CT
CT changes the diagnostic problem from physiology to anatomy.
Instead of asking:
“Is the pulmonary artery enlarged?”
the radiologist can ask:
“Where does each pulmonary vein actually drain?”
This distinction is fundamental.
| Axial |
| Sagittal |
Figure 4. Contrast-Enhanced Chest CT: Axial and Sagittal Reconstruction
The case demonstrates right-sided cardiac enlargement and pulmonary arterial enlargement. More importantly, the pulmonary venous pathways can be followed directly.
The key anatomy is:
Right upper pulmonary vein → SVC
Right middle pulmonary vein → right-sided circulation in association with sinus venosus defect
Right lower pulmonary vein → left atrium
This combination establishes partial rather than total anomalous pulmonary venous return.
8. The Most Important CT Skill: Map Every Pulmonary Vein
One abnormal pulmonary vein is not enough.
This is perhaps the most important practical lesson from the case.
If the right upper pulmonary vein drains into the SVC, the examination is not finished.
The next question is:
Where do the remaining pulmonary veins drain?
A useful systematic approach is:
A complete map is essential before surgical planning.
The source case explicitly recommends this systematic sequence and emphasizes that axial, sagittal, coronal, MIP, and three-dimensional reconstructions can transform CT into a preoperative anatomical map.
9. Coronal CT: The Surgical Anatomy Becomes Visible
Coronal reformations are particularly valuable because the vertical relationship among the pulmonary veins, SVC, and atrial structures can become much easier to understand.
Figure 5. Coronal Contrast-Enhanced CT
Coronal CT reconstruction demonstrating anomalous right-sided pulmonary venous drainage toward the systemic venous circulation, with associated right-heart and pulmonary arterial enlargement.
Radiologist Interpretation:
The coronal plane provides a longitudinal view of the anomalous venous pathway. When combined with axial and sagittal imaging, it helps establish the exact drainage site and relationship between the pulmonary veins and SVC.
The case also describes small pericardial and left pleural effusions with adjacent atelectatic change. These findings are secondary observations and should not distract from the principal congenital cardiovascular diagnosis.
10. Radiologist Reading Report
Findings
Cardiomegaly with enlargement of the right-sided cardiac chambers and dilatation of the main and central pulmonary arteries.
Abnormal drainage of the right upper pulmonary vein into the superior vena cava. Additional anomalous right middle pulmonary venous drainage toward the right-sided circulation is associated with a superior sinus venosus atrial septal defect. The right lower pulmonary vein drains normally into the left atrium.
Small pericardial and left pleural effusions with adjacent atelectatic change.
Impression
Partial anomalous pulmonary venous return involving the right upper and middle pulmonary veins, associated with a superior sinus venosus atrial septal defect. The right lower pulmonary vein drains normally into the left atrium. Associated right-sided cardiac and pulmonary arterial enlargement suggests chronic left-to-right shunting.
The source case provides this diagnostic formulation essentially and stresses that the precise anomalous drainage sites should be stated rather than simply reporting “PAPVR.”
11. Why CT Is So Valuable
For this specific anatomical problem, CT offers several advantages.
It can:
Trace pulmonary veins from lung to their drainage site.
Demonstrate the SVC and systemic venous anatomy.
Define the relationship between pulmonary veins and the atrial septum.
Assess right atrial and ventricular enlargement.
Evaluate pulmonary artery dimensions.
Identify additional thoracic abnormalities.
Produce multiplanar and three-dimensional reconstructions.
Provide a detailed preoperative anatomical roadmap.
The AHA/ACC guideline specifically identifies CMR or CCT as ideal cross-sectional techniques for delineating anomalous pulmonary venous connections, while noting the particular value of CMR for quantifying shunt magnitude without ionizing radiation.
A contemporary radiology review similarly emphasizes multidetector CT for defining the morphological variability and associated anomalies of PAPVC.
12. Where Cardiac MRI Adds Value
CT answers an anatomical question exceptionally well:
Where does the blood go?
Cardiac MRI can go further:
How much blood is going there, and what is the physiological consequence?
Important MRI questions include:
What is the right ventricular size?
What is right ventricular function?
What is the magnitude of the left-to-right shunt?
What is the Qp/Qs ratio?
What is pulmonary blood flow?
Is there residual shunting after repair?
MRI is particularly valuable when repeated assessment is anticipated because it does not require ionizing radiation.
The AHA/ACC guideline specifically notes the advantage of CMR for shunt quantification in patients with anomalous pulmonary venous connections.
13. Multimodality Imaging Comparison
| Modality | Major Strength | Major Limitation | Best Clinical Role |
|---|---|---|---|
| Chest X-ray | Recognizes cardiomegaly and pulmonary arterial prominence | Cannot reliably map anomalous venous anatomy | Initial clue |
| TTE | Cardiac chambers, function, pressure estimates | Limited visualization of superior/posterior atrial septum and extracardiac veins | Initial cardiac assessment |
| TEE | Better atrial septal and selected pulmonary venous visualization | Semi-invasive; incomplete visualization of some extracardiac pathways | Detailed septal assessment |
| CT angiography | Excellent spatial resolution and complete vascular mapping | Ionizing radiation and iodinated contrast | Anatomical diagnosis and surgical planning |
| Cardiac MRI | Anatomy plus ventricular function and flow quantification | Longer examination, availability, motion sensitivity | Hemodynamic assessment and follow-up |
| 4D-flow MRI | Potentially detailed flow characterization | Limited availability and complex analysis | Advanced research/precision assessment |
The guideline literature supports a complementary rather than competitive approach: TTE remains important, but cross-sectional imaging is particularly valuable when pulmonary venous anatomy cannot be completely defined by echocardiography.
14. Differential Diagnosis
Table 2. Imaging Differential Diagnosis of PAPVR
| Diagnosis | CT Appearance | MRI/Functional Clue | Key Differentiating Point |
|---|---|---|---|
| PAPVR | One or more pulmonary veins drain into systemic venous circulation | Left-to-right shunt | Some pulmonary veins still drain normally into LA |
| TAPVR | All pulmonary veins have abnormal drainage | Major abnormal pulmonary venous return | No normal pulmonary venous connection to LA |
| Scimitar syndrome | Right lower pulmonary vein drains toward IVC | Right-sided flow abnormality | Characteristic anomalous inferior venous drainage |
| Pulmonary venous varix | Focal venous dilatation | Usually localized vascular abnormality | No systemic anomalous drainage pathway |
| Persistent left SVC | Left mediastinal venous channel | Venous return anomaly | Does not itself represent anomalous pulmonary venous drainage |
| Vertical vein anomaly | Vertical venous channel toward innominate vein/SVC | Depends on associated anatomy | Must trace continuity with pulmonary veins |
| Secundum ASD | Defect near fossa ovalis | Left-to-right shunt | Typical location differs from superior sinus venosus defect |
The source case specifically identifies TAPVR, pulmonary venous varix, persistent left SVC, and scimitar syndrome as important alternatives.
15. PAPVR Versus TAPVR: The Critical Distinction
This distinction should never depend on the size of the abnormal vessel.
It depends on how many pulmonary veins drain abnormally.
In PAPVR:
At least one pulmonary vein remains connected to the left atrium.
In TAPVR:
All pulmonary venous return is anomalous.
In this case, the normal right lower pulmonary venous connection to the left atrium is decisive evidence supporting PAPVR rather than TAPVR.
16. Treatment: Anatomy Alone Does Not Determine the Operation
Not every patient with PAPVR requires surgery.
The decision should incorporate:
Symptoms
Functional capacity
Number of anomalous veins
Right ventricular enlargement
Right atrial enlargement
Qp/Qs
Pulmonary artery pressure
Pulmonary vascular resistance
Associated ASD
Arrhythmias
Pulmonary hypertension
Surgical risk
The AHA/ACC guideline notes that isolated anomalous connection involving only one pulmonary lobe rarely produces enough volume load to justify repair, whereas symptomatic patients with more than one anomalous vein and a moderate or large left-to-right shunt may benefit from surgical correction.
This distinction is particularly important in elderly patients.
Age alone should not automatically exclude intervention, but advanced age may alter operative risk, ventricular reserve, pulmonary vascular status, and the balance between expected benefit and procedural risk.
17. Surgical Principles
The objectives of surgery are fundamentally anatomical and physiological:
Redirect anomalous pulmonary venous blood to the left atrium.
Correct the associated sinus venosus defect.
Restore an appropriate circulation without creating pulmonary venous or systemic venous obstruction.
Depending on anatomy, surgical strategies can include:
Intracardiac baffling
Warden-type procedures
Direct pulmonary vein reimplantation
ASD patch closure
Reconstruction of the SVC pathway
The AHA/ACC guideline describes intracaval baffling, Warden procedures, and direct reimplantation as established surgical approaches, while also noting that anomalous pulmonary venous surgery can be technically challenging because venous flow is relatively low and postoperative thrombosis can occur.
Sinus venosus defects are also fundamentally different from secundum ASDs from a device-closure perspective. The guideline notes that sinus venosus defects generally require surgical rather than conventional transcatheter closure because of their anatomy and frequent association with anomalous pulmonary venous connections.
18. Why Timing Matters
A patient who has remained asymptomatic for decades can create a false sense of security.
Chronic left-to-right shunting can gradually remodel the right heart and pulmonary vasculature.
The key clinical issue is not simply:
“Is the patient symptomatic today?”
It is:
“Has the shunt already produced structural or hemodynamic consequences?”
Once substantial pulmonary vascular disease develops, the risk-benefit equation for correction changes.
The source case emphasizes that treatment decisions should be based on current hemodynamic status, pulmonary vascular resistance, right ventricular condition, and shunt burden rather than age alone.
19. Palpitations as a Structural Heart Disease Clue
Palpitations are common.
PAPVR is not.
That is exactly why the diagnosis can be missed.
The useful combination is not:
palpitations → PAPVR
but:
palpitations + right-heart enlargement + pulmonary arterial enlargement → investigate chronic right-sided volume loading.
Long-standing right atrial enlargement may provide a substrate for atrial arrhythmias.
Thus, ECG and Holter monitoring can identify the rhythm problem while imaging identifies the structural reason the rhythm problem developed.
This is an important example of why clinical imaging should not be isolated from physiology.
20. Artificial Intelligence Perspective
AI can potentially improve PAPVR detection, but its role should be defined carefully.
A conventional computer vision system could be trained to identify:
Enlarged right atrium
Enlarged right ventricle
Dilated pulmonary arteries
Abnormal mediastinal vascular structures
Suspicious pulmonary venous pathways
A more advanced system could attempt automated pulmonary venous segmentation.
The workflow could be:
DICOM CT → pulmonary vessel segmentation → pulmonary vein classification → drainage-pathway reconstruction → anomaly detection → right-heart volumetric analysis → clinical decision support
Figure 6. AI-Enabled PAPVR Imaging Workflow
Conceptual enterprise AI pipeline for PAPVR assessment. CT images are processed through vessel segmentation and anatomical classification, followed by pulmonary venous pathway reconstruction, right-heart volumetry, anomaly detection, and integration with clinical and hemodynamic information.
21. Radiomics and Foundation Models
Radiomics could potentially quantify:
Right ventricular morphology
Pulmonary arterial dimensions
Cardiac chamber geometry
Pulmonary vascular patterns
Postoperative remodeling
However, PAPVR is primarily an anatomical connectivity problem.
This is a crucial limitation.
A model may detect enlarged pulmonary arteries extremely well without understanding why they are enlarged.
A radiologist must therefore determine the causal anatomy.
Foundation models and vision-language models may eventually provide more sophisticated multimodal reasoning by combining:
CT anatomy
Echocardiography
Cardiac MRI
ECG
Laboratory data
Clinical history
Surgical records
But an AI-generated statement such as “possible congenital shunt” should never replace direct verification of the pulmonary venous drainage pathway.
22. PACS, HL7, and FHIR: From Algorithm to Clinical Workflow
The practical value of AI depends on integration.
A standalone model that identifies a vascular anomaly but does not communicate effectively with the clinical workflow has limited clinical utility.
A mature enterprise architecture could connect:
HL7 and FHIR can facilitate exchange of structured clinical information, while DICOM remains central to imaging interoperability.
A future system could automatically trigger a congenital-heart-disease review when the AI detects:
Right ventricular enlargement
Pulmonary arterial enlargement
Suspicious anomalous venous anatomy
The radiologist would then receive an explainable overlay showing the suspected pulmonary venous pathway.
That is much more clinically meaningful than simply displaying an AI probability score.
23. Where AI Can Fail
AI systems may fail when:
Pulmonary veins have unusual branching anatomy.
Contrast timing is suboptimal.
Motion artifact obscures the atrial septum.
Multiple anomalous connections coexist.
Postoperative anatomy is present.
The training dataset underrepresents adult congenital heart disease.
The model encounters unfamiliar scanner protocols.
The system confuses systemic veins with pulmonary veins.
It recognizes an enlarged pulmonary artery but fails to identify the cause.
The radiologist therefore remains responsible for confirming:
origin → course → drainage site → associated defect → physiological consequence.
24. Future Precision Imaging
The future of PAPVR management is likely to involve multimodal rather than purely anatomical diagnosis.
Radiogenomics
May eventually help connect imaging phenotype with biological variation, although PAPVR currently remains primarily an anatomical congenital diagnosis rather than a radiogenomic disease entity.
Digital Twins
A patient-specific cardiovascular model could simulate:
Shunt magnitude
Right ventricular loading
Pulmonary blood flow
Surgical rerouting
Potential postoperative hemodynamics
Federated Learning
Multiple congenital heart centers could potentially train models across institutions without transferring identifiable patient data.
Synthetic Data
Synthetic cardiovascular CT datasets may help address the rarity of congenital vascular anomalies and improve algorithm development.
Multimodal AI
25. Clinical Pearls
PAPVR is a connectivity diagnosis. The essential question is where each pulmonary vein drains.
A right upper pulmonary vein draining into the SVC is a classic PAPVR pattern.
Superior sinus venosus ASD and right-sided PAPVR frequently coexist.
Never stop after identifying one anomalous pulmonary vein.
Confirm which pulmonary veins remain normally connected to the left atrium.
Right atrial and right ventricular enlargement suggest chronic right-sided volume loading.
Pulmonary arterial enlargement may be a clue to chronic pulmonary overcirculation.
Palpitations in an adult with right-heart enlargement deserve structural evaluation.
Chest radiography usually suggests the physiology rather than proving the anatomical diagnosis.
CT angiography is particularly valuable for preoperative pulmonary venous mapping.
Cardiac MRI adds important physiological information, including shunt quantification.
PAPVR should be distinguished carefully from TAPVR.
Scimitar syndrome is characterized by anomalous right lower pulmonary venous drainage toward the IVC.
PAPVR itself does not automatically mean surgery.
Treatment should be based on anatomy, symptoms, right-heart remodeling, shunt magnitude, pulmonary pressures, and pulmonary vascular resistance.
Quiz
Question 1
A 70-year-old man presents with palpitations. Chest radiography demonstrates cardiomegaly and pulmonary arterial enlargement. CT shows right upper pulmonary venous drainage into the SVC and a superior sinus venosus ASD. The right lower pulmonary vein drains normally into the left atrium. What is the most likely diagnosis?
① Secundum ASD
② Total anomalous pulmonary venous return
③ Partial anomalous pulmonary venous return with sinus venosus ASD
④ Scimitar syndrome
⑤ Pulmonary venous varix
Answer: ③
Explanation: The combination of anomalous right-sided pulmonary venous drainage, a superior sinus venosus defect, and at least one pulmonary vein draining normally into the left atrium establishes PAPVR rather than TAPVR.
Question 2
What is the single most important CT task when evaluating suspected PAPVR?
① Counting pulmonary nodules
② Determining the drainage pathway of every pulmonary vein
③ Measuring pleural thickness
④ Evaluating bronchiectasis
⑤ Measuring liver size
Answer: ②
Explanation: PAPVR is defined by abnormal pulmonary venous connectivity. Complete pulmonary venous mapping is therefore more important than simply identifying an enlarged or unusual vessel.
Question 3
Which combination most strongly supports consideration of surgical correction in an adult with PAPVR?
① No symptoms, normal RV, minimal shunt
② RV enlargement, functional impairment, and significant left-to-right shunt
③ Normal cardiac size and normal pulmonary pressure
④ Small pleural effusion alone
⑤ Palpitations without evidence of structural or hemodynamic burden
Answer: ②
Explanation: Surgical decision-making depends on clinically significant shunting and its physiological consequences. The AHA/ACC guideline identifies symptomatic patients with multiple anomalous veins and a moderate or large left-to-right shunt as potential candidates for repair, provided pulmonary vascular status is appropriate.
Frequently Asked Questions
1. What is PAPVR?
PAPVR is a congenital anomaly in which one or more pulmonary veins drain into the systemic venous circulation rather than exclusively into the left atrium.
2. Is PAPVR the same as TAPVR?
No. In PAPVR, some pulmonary veins still drain normally into the left atrium. TAPVR involves anomalous drainage of the entire pulmonary venous system.
3. What is the most common PAPVR pattern?
A common pattern is drainage of the right upper pulmonary vein into the superior vena cava.
4. Why is sinus venosus ASD associated with PAPVR?
Superior sinus venosus defects develop near the SVC–right atrial junction and are closely associated with anomalous right-sided pulmonary venous drainage.
5. Can PAPVR remain undiagnosed until old age?
Yes. Small or moderate shunts can remain clinically silent for many years.
6. Can PAPVR cause palpitations?
Yes. Chronic right atrial and ventricular volume loading can contribute to atrial enlargement and arrhythmogenic remodeling.
7. Is CT better than echocardiography for PAPVR?
CT provides excellent visualization of extracardiac pulmonary venous anatomy. Echocardiography remains essential for cardiac assessment but may have limitations in visualizing superior/posterior structures.
8. What does cardiac MRI add?
MRI can assess ventricular function and quantify shunt physiology without ionizing radiation.
9. Does every PAPVR require surgery?
No. Treatment depends on symptoms, shunt magnitude, right-heart remodeling, pulmonary pressures, pulmonary vascular resistance, and associated defects.
10. What is the most important radiology principle?
Trace every pulmonary vein to its final drainage site.
Ultimate Guide to PAPVR
The cornerstone of PAPVR diagnosis is not recognizing an unusual vessel.
It is reconstructing the entire pulmonary venous circulation.
A reliable diagnostic framework is:
This framework is more robust than memorizing individual anatomical variants.
Final Expert Perspective
PAPVR is easy to underestimate because the anatomical abnormality may appear deceptively small.
The clinical consequences, however, depend not on the visual size of the anomalous vein but on the physiological burden created by the abnormal connection.
The central lesson from this case is therefore not simply that PAPVR can occur in an elderly patient.
It is that adult congenital heart disease can reveal itself indirectly through a combination of common findings.
Palpitations may be common.
Cardiomegaly may be common.
Pulmonary arterial enlargement may be common.
But their combination can reveal a congenital shunt that has persisted for decades.
From a radiologist's perspective, the decisive step is to reconstruct the blood-flow anatomy.
The report should answer four questions:
Which pulmonary vein is abnormal?
Where does it drain?
Is a sinus venosus defect present?
What physiological consequences has the shunt produced?
CT is particularly powerful because it can convert these questions into a three-dimensional anatomical map. Cardiac MRI then provides complementary physiological information, particularly when quantification of shunting and ventricular remodeling is important. Current adult congenital heart disease guidance supports cross-sectional imaging with CMR or CCT for delineating anomalous pulmonary venous connections, while management should be based on the clinical and hemodynamic consequences rather than the anatomical label alone.
The ultimate objective of imaging is therefore not merely to diagnose PAPVR.
It is to explain the patient's physiology, define the anatomy precisely, communicate the information needed for multidisciplinary decision-making, and identify the patients in whom an apparently incidental congenital anomaly has become clinically significant.
In this setting, the most important sentence in the radiology report may be the simplest:
“Follow every pulmonary vein to where it drains.”
That is where the diagnosis begins—and where high-quality cardiovascular imaging becomes clinically actionable.
References
K. K. Stout, C. J. Daniels, J. A. Aboulhosn, et al., “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease,” Circulation, vol. 139, pp. e698–e800, 2019, doi: 10.1161/CIR.0000000000000603.
H. Baumgartner, J. De Backer, S. V. Babu-Narayan, et al., “2020 ESC Guidelines for the management of adult congenital heart disease,” European Heart Journal, vol. 42, no. 6, pp. 563–645, 2021, doi: 10.1093/eurheartj/ehaa554.
A. K. Verma, S. Sethi, and N. Kohli, “Partial anomalous pulmonary venous connection: state-of-the-art review with assessment using a multidetector computed tomography angiography,” Polish Journal of Radiology, vol. 87, pp. e549–e556, 2022, doi: 10.5114/pjr.2022.120513.
C.-C. Chang and C.-Y. Lin, “Partial Anomalous Pulmonary Venous Return,” Radiology, vol. 302, no. 3, p. 513, 2022, doi: 10.1148/radiol.2021212103.
L. B. Haramati, I. E. Moche, V. T. Rivera, et al., “Computed tomography of partial anomalous pulmonary venous connection in adults,” Journal of Computer Assisted Tomography, vol. 27, no. 5, pp. 743–749, 2003, doi: 10.1097/00004728-200309000-00011.
L. Sun, C. Pang, X. Wang, M. Xu, Z. Zhang, and S. Wang, “Partial Anomalous Pulmonary Venous Connection and the Nature of Associated Sinus Venosus Defect,” Congenital Heart Disease, vol. 17, no. 2, pp. 201–214, 2022, doi: 10.32604/chd.2022.018453.
R. Wojtal, A. Spirig, T. Ohletz, L. M. Haegeli, and T. A. Fuchs, “Sinus Venosus Atrial Septal Defect with Partial Anomalous Pulmonary Vein Return,” Cardiovascular Medicine, vol. 25, no. 4, p. 124, 2022, doi: 10.4414/cvm.2022.02215.
J. M. Bonelli-Sica, R. D. Mora-Cervantes, M. Diaz-Zamudio, et al., “Dual-source 256-MDCT for diagnosis of anomalous pulmonary venous drainage in pediatric population,” AJR American Journal of Roentgenology, vol. 200, pp. W163–W169, 2013, doi: 10.2214/AJR.11.8348.
M. H. H. Toprak, E. Öztürk, A. C. Hatemi, et al., “Does Transcatheter Therapy Replace Surgery? Transcatheter Closure of Sinus Venosus Atrial Septal Defect and Partial Pulmonary Venous Return,” Anatolian Journal of Cardiology, vol. 27, no. 11, pp. 673–674, 2023, doi: 10.14744/AnatolJCardiol.2023.3302.
P. Bhatt, R. Vempati, M. Sanusi, et al., “Sinus Venosus Atrial Septal Defect with Partial Anomalous Pulmonary Venous Return Presenting With Hyponatremia and Bradyarrhythmia,” JACC, vol. 87, no. 13 Supplement, pp. A1405–A1406, 2026, doi: 10.1016/j.jacc.2026.02.3489.
P. Festa, L. Ait-Ali, A. G. Cerillo, et al., “Magnetic resonance imaging is the diagnostic tool of choice in the preoperative evaluation of patients with partial anomalous pulmonary venous return,” International Journal of Cardiovascular Imaging, vol. 22, pp. 685–693, 2006.
S. Nordmeyer, F. Berger, T. Kuehne, et al., “Flow-sensitive four-dimensional magnetic resonance imaging facilitates and improves the accurate diagnosis of partial anomalous pulmonary venous drainage,” Cardiology in the Young, vol. 21, pp. 528–535, 2011.
J. L. Dyme, A. Prakash, B. F. Printz, et al., “Physiology of isolated anomalous pulmonary venous connection of a single pulmonary vein as determined by cardiac magnetic resonance imaging,” American Journal of Cardiology, vol. 98, pp. 107–110, 2006.
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery, Circulation, 2024. The guideline emphasizes specialized perioperative assessment in adults with congenital heart disease, particularly when pulmonary hypertension, heart failure, poor functional capacity, or complex anatomy is present.
ESC Working Group on Adult Congenital Heart Disease, “Three-dimensional echocardiography in adults with congenital heart disease: a scientific statement,” European Heart Journal – Cardiovascular Imaging, 2025.
Medical Disclaimer
This article is intended for medical education and professional information. It does not replace individualized diagnosis, treatment planning, or consultation with a qualified physician. Management of PAPVR and sinus venosus ASD should be determined through multidisciplinary assessment incorporating anatomy, symptoms, ventricular remodeling, shunt magnitude, pulmonary pressures, pulmonary vascular resistance, and overall patient risk.
Comments
Post a Comment